Patents Assigned to Astra Pharma Inc.
  • Patent number: 7297771
    Abstract: The present invention concerns novel polypeptides having opioid receptor activity, the genetic material permitting their expression, recombinant cells expressing these polypeptides, and their use.
    Type: Grant
    Filed: May 12, 2003
    Date of Patent: November 20, 2007
    Assignee: Astra Pharma Inc.
    Inventor: Brigitte Kieffer
  • Publication number: 20040096940
    Abstract: The present invention concerns novel polypeptides having opioid receptor activity, the genetic material permitting their expression, recombinant cells expressing these polypeptides, and their use.
    Type: Application
    Filed: May 12, 2003
    Publication date: May 20, 2004
    Applicant: ASTRA PHARMA INC.
    Inventor: Brigitte Kieffer
  • Patent number: 6562587
    Abstract: The present invention concerns novel polypeptides having opioid receptor activity, the genetic material permitting their expression, recombinant cells expressing these polypeptides, and their use.
    Type: Grant
    Filed: May 10, 1995
    Date of Patent: May 13, 2003
    Assignee: Astra Pharma Inc.
    Inventor: Brigitte Kieffer
  • Publication number: 20030055045
    Abstract: Compounds of general formula (I) 1
    Type: Application
    Filed: April 15, 2002
    Publication date: March 20, 2003
    Applicant: Astra Pharma Inc.
    Inventors: Benjamin Pelcman, Edward Roberts
  • Publication number: 20010021715
    Abstract: Compounds of general formula (I) 1
    Type: Application
    Filed: January 18, 2001
    Publication date: September 13, 2001
    Applicant: Astra Pharma Inc.
    Inventors: Daniel Delorme, Edward Roberts, Zhongyong Wei
  • Patent number: 6187792
    Abstract: Compounds of general formula (I) are disclosed and claimed in the present application, as well as their pharmaceutically acceptable salts, pharmaceutical compositions comprising the novel compounds and their use in therapy, in particular in the management of pain.
    Type: Grant
    Filed: March 5, 1998
    Date of Patent: February 13, 2001
    Assignee: Astra Pharma Inc.
    Inventors: Daniel Delorme, Edward Roberts, Zhongyong Wei
  • Patent number: 6153626
    Abstract: Compounds of general formula (I) ##STR1## wherein m is 0 or 1, and n is 1 or 2; are disclosed and claimed in the present application, as well as their pharmaceutically acceptable salts, pharmaceutical compositions comprising the novel compounds and their use in therapy, in particular in the management of pain.
    Type: Grant
    Filed: March 3, 1998
    Date of Patent: November 28, 2000
    Assignee: Astra Pharma Inc.
    Inventors: Benjamin Pelcman, Edward Roberts
  • Patent number: 6130222
    Abstract: Compounds of the formula (I) ##STR1## as well as their pharmaceutically acceptable salts, and pharmaceutical compositions comprising the novel compounds. The novel compounds of the formula (I) are useful in the management of pain.
    Type: Grant
    Filed: April 24, 1997
    Date of Patent: October 10, 2000
    Assignee: Astra Pharma Inc.
    Inventors: Edward Roberts, Niklas Plobeck, Claes Wahlestedt